(Q52382138)

30 April 2018

title

Role of islet amyloid polypeptide secretion in insulin-resistant humans. (English)

1 reference

30 April 2018

1 reference

1 reference

Alexandra Kautzky-Willer

1

1 reference

30 April 2018

Karl Thomaseth

2

1 reference

30 April 2018

author name string

G Pacini

3

1 reference

30 April 2018

M Clodi

4

1 reference

30 April 2018

B Ludvik

5

1 reference

30 April 2018

C Streli

6

1 reference

30 April 2018

W Waldhäusl

7

1 reference

30 April 2018

R Prager

8

1 reference

30 April 2018

publication date

1 February 1994

1 reference

30 April 2018

published in

Diabetologia

1 reference

30 April 2018

volume

37

1 reference

30 April 2018

issue

2

1 reference

30 April 2018

page(s)

188-194

1 reference

30 April 2018

https://scigraph.springernature.com/pub.10.1007/s001250050092

exact match

0 references

cites work

Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs.

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Lack of Effect of Islet Amyloid Polypeptide in Causing Insulin Resistance in Conscious Dogs During Euglycemic Clamp Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Decrease of Stimulated Amylin Release Precedes Impairment of Insulin Secretion in Type II Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Islet amyloid polypeptide--a novel controversy in diabetes research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Elevated hepatic insulin extraction in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Beta-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Islet Amyloid Polypeptide and Insulin Secretion From Isolated Perfused Pancreas of Fed, Fasted, Glucose-Treated, and Dexamethasone-Treated Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Presence of Liver CGRP/Amylin Receptors in Only Nonparenchymal Cells and Absence of Direct Regulation of Rat Liver Glucose Metabolism by CGRP/Amylin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

Effects of islet amyloid polypeptide on hepatic insulin resistance and glucose production in the isolated perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050092

The kinetics of insulin in man. II. Role of the liver

21 January 2018

1 reference

12 December 2020

PANSYM: a symbolic equation generator for mathematical modelling, analysis and control of metabolic and pharmacokinetic systems.

1 reference

12 December 2020

Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells

1 reference

12 December 2020

Glucose Stimulates and Potentiates Islet Amyloid Polypeptide Secretion by the B-Cell

1 reference

12 December 2020

Cosecretion of amylin and insulin from isolated rat pancreas

1 reference

12 December 2020

Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells

1 reference

12 December 2020

Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effects of exogenous somatostatin and insulin on islet amyloid polypeptide (amylin) release from perfused rat pancreas

1 reference

12 December 2020

Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets

1 reference

12 December 2020

Increased glomerular filtration rate and adrenocortical function in obese women

1 reference

12 December 2020

Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment

1 reference

12 December 2020

Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration

1 reference

12 December 2020

Identifiers

DOI

10.1007/S001250050092

1 reference

30 April 2018

1 reference

30 April 2018